Sign up to save your podcasts
Or
Share ERJ Podcast March 2025: Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ERJ Podcast March 2025: Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.
View all episodes
By ERS Publications Podcasts
3.8
44 ratings
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.
More shows like ERS Publications Podcasts
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
318 Listeners
JAMA Clinical Reviews
496 Listeners
Medicine and Science from The BMJ
37 Listeners
CHEST Journal Podcasts
64 Listeners
Thorax Podcast
2 Listeners
Out of the Blue: An AJRCCM Podcast
37 Listeners
ATS Breathe Easy
36 Listeners
BMJ Best Practice Podcast
23 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
85 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
The Respiratory Futures Podcast
0 Listeners
What's Up Docs?
106 Listeners